Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Care 29:668-672, 2006
DOI: 10.2337/diacare.29.03.06.dc05-0970
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sierra-Johnson, J.
Right arrow Articles by Turner, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sierra-Johnson, J.
Right arrow Articles by Turner, S. T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Article

Correspondence Between the Adult Treatment Panel III Criteria for Metabolic Syndrome and Insulin Resistance

Justo Sierra-Johnson, MD, MS1, Bruce D. Johnson, PHD1, Thomas G. Allison, PHD, MPH1, Kent R. Bailey, PHD2, Gary L. Schwartz, MD1 and Stephen T. Turner, MD1

1 Divisions of Nephrology and Hypertension and Cardiovascular Diseases, Department of Internal Medicine, Rochester, Minnesota
2 Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minnesota

Address correspondence and reprint requests to Stephen T. Turner, MD, Division of Nephrology and Hypertension, Mayo Clinic, 200 First St. SW, Rochester, MN 55905. E-mail: sturner{at}mayo.edu

OBJECTIVE—The aim of the present study was to assess the diagnostic accuracy of the Adult Treatment Panel III (ATP-III) definition of the metabolic syndrome in identifying insulin-resistant individuals and to explore alternative approaches to improve identification of insulin-resistant individuals among asymptomatic adults from the general population.

RESEARCH DESIGN AND METHODS—The sample consisted of 256 non-Hispanic white subjects without treated hypertension or diabetes, from the Rochester (Minnesota) Heart Family Study (123 men and 133 women; aged 20–60 years). Frequently sampled intravenous glucose tolerance tests were performed in all subjects. The reference standard for insulin resistance was determined by Bergman’s minimal model; insulin resistance was defined as an insulin sensitivity index <2 x 10 min–1 · µU–1 · ml–1. Component metabolic syndrome measures included blood pressure determined by sphygmomanometer; fasting serum triglycerides, HDL cholesterol, and glucose concentrations determined enzymatically; and waist circumference determined by tape measure.

RESULTS—By ATP-III criteria, the prevalence of metabolic syndrome was 15.6% (16.3% in men and 15.1% in women; P = 0.465). The presence of metabolic syndrome had low sensitivity to identify insulin resistance (45% in men and 39% in women; sex difference, P = 0.137) but high specificity (93% in men and 95% in women; sex difference, P = 0.345). Based on the area under the receiver operating characteristic curve (AUC) constructed by counting metabolic syndrome components as recommended by ATP-III, diagnostic accuracy was fair (AUC = 0.797 in men and 0.747 in women). When component metabolic syndrome measures were considered as quantitative traits rather than dichotomized, use of waist circumference alone, rather than counting metabolic syndrome components, improved diagnostic accuracy for insulin resistance (in men, AUC = 0.906, P = 0.001; in women, AUC = 0.822, P = 0.10).

CONCLUSIONS—Application of the ATP-III metabolic syndrome criteria provides good specificity but low sensitivity to screen asymptomatic white adults for insulin resistance. Measuring just waist circumference is simpler and may provide greater accuracy for identifying insulin resistance.

Abbreviations: ATP-III, Adult Treatment Panel III • AUC, area under the curve • CHD, coronary heart disease • FSIVGTT, frequently sampled intravenous glucose tolerance test • GCRC, General Clinical Research Center • RFHS, Rochester Family Heart Study • ROC, receiver operating characteristic


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
R. Kahn
Metabolic Syndrome: Is It a Syndrome? Does It Matter?
Circulation, April 3, 2007; 115(13): 1806 - 1811.
[Full Text] [PDF]


Home page
Diabetes CareHome page
J. J. Fogli-Cawley, J. T. Dwyer, E. Saltzman, M. L. McCullough, L. M. Troy, J. B. Meigs, and P. F. Jacques
The 2005 Dietary Guidelines for Americans and Insulin Resistance in the Framingham Offspring Cohort
Diabetes Care, April 1, 2007; 30(4): 817 - 822.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.